IFP Advisors’s Agile Therapeutics AGRX Stock Holding History

IFP Advisors’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3	Closed	-$5K	–	3531
2021 Q3	$5K	Hold	3	–	–	﹤0.01%	2591
2021 Q2	$7K	Hold	3	–	–	﹤0.01%	2372
2021 Q1	$10K	Hold	3	–	–	﹤0.01%	2153
2020 Q4	$14K	Hold	3	–	–	﹤0.01%	1941
2020 Q3	$15K	Hold	3	–	–	﹤0.01%	1767
2020 Q2	$14K	Hold	3	–	–	﹤0.01%	1710
2020 Q1	$10K	Hold	3	–	–	﹤0.01%	1798
2019 Q4	$12K	Buy	+3	New	+$10.5K	﹤0.01%	1860
2018 Q2	–	Sell	-2	Closed	-$9K	–	4125
2018 Q1	$9K	Hold	2	–	–	﹤0.01%	2873
2017 Q4	$9K	Buy	+2	New	+$18.6K	﹤0.01%	2918
2017 Q1	–	Sell	-1	Closed	-$10K	–	4185
2016 Q4	$10K	Buy	+1	New	+$14K	﹤0.01%	2928

Other funds holding AGRX

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return